North America Diagnostic Imaging Systems Market To Value $17.7 Billion In 2024

By Author: Pramod Kumar
Total Articles: 97
Comment this article

The growing awareness on the early diagnosis of chronic diseases, which are rising in prevalence, increasing healthcare expenditure, and rapid technological developments are expected to drive the growth of the North American diagnostic imaging systems market at a CAGR of 5.0% during the forecast period (2019–2024). With this growth rate, the market value is expected to reach $17.7 billion by 2024. North America boasts the world’s most advanced healthcare system, characterized by the widespread usage of different types of imaging systems for diagnostic purposes.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/north-america-diagnostic-imaging-systems-market/report-sample

In addition, the North American diagnostic imaging systems market is advancing with the increase in the number of people aged 65 years and above. Since the elderly people are more prone to chronic diseases, such as cardiac disorders, gastrointestinal problems, and cancer, which often require advanced diagnostic imaging technologies for their diagnosis, the demand for these systems in the country is ...
... increasing with the surge in the geriatric population. The U.S. Census Bureau says that this population in the country rose swiftly from 40.3 million in 2010 to 54 million in mid-2019.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=north-america-diagnostic-imaging-systems-market

Moreover, companies in the North American diagnostic imaging systems market, such as Esaote S.p.A., FUJIFILM Holdings Corporation, Karl Storz GmbH & Co. KG, Carestream Health Inc., General Electric Company, Koninklijke Philips N.V., Esaote S.p.A., and Siemens AG, are actively focusing on the development of advanced diagnostic imaging solutions, for better image quality and visualization of internal organs. To meet the increasing demand for diagnostic imaging devices, improve patients’ access to novel technologies, augment their market share and presence, and enhance patient outcomes, these companies are also indulging in collaborations and acquisitions.

For example, in January 2019, Koninklijke Philips N.V., one of the largest companies in the North American diagnostic imaging systems market, launched an advanced image-guided therapy platform, Azurion with FlexArm, which makes it easier for clinicians to perform imaging in both 2D and 3D formats. In the same way, in November 2018, GE Healthcare announced its plan to partner with Veterans Affairs (VA) Puget Sound Health Care System to increase the adoption of 3D imaging in healthcare.

Thus, the widening portfolio of diagnostic imaging devices is expected to propel the demand for such systems in the continent.

Pramod has around 7 years of experience in market research and consulting services for healthcare industry. He holds varied experience in market sizing and forecasting with varied models, competition landscape, consumer behavior analysis, opportunity analysis, product/company benchmarking, data mining and others. He has successfully delivered multiple projects on go-to-market strategies, pricing strategy, price point analysis, Business Expansion, market entry and exit, share analysis and others. Prior to joining P&S Intelligence, he worked with different research companies, including Transparency Market Research and MarketsandMarkets Pvt Ltd. Some of the projects delivered by him include Scar Treatment Market, Skin Replacement and Substitutes Market, and Energy-Based Aesthetic Devices Market.